Grüezi! Sie wurden auf, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
SMI 10'129 -0.9%  SPI 12'974 -1.0%  Dow 29'226 -1.5%  DAX 11'976 -1.7%  Euro 0.9573 0.7%  EStoxx50 3'279 -1.7%  Gold 1'660 0.0%  Bitcoin 18'975 -0.1%  Dollar 0.9766 0.0%  Öl 88.6 -0.8% 
News + Analysen
News + Adhoc
zugeh. Wertpapiere
Strukturierte Produkte
18.08.2022 16:53:00

2 Red Flags and 1 Green Flag For Illumina Stock

In the world of gene sequencing, few names carry as much weight as Illumina (NASDAQ: ILMN). Its sequencing devices are among the most widely distributed in global hospitals and laboratories of all stripes, and its ongoing years-long efforts to develop new technologies place it at the cutting edge of the field, with few notable competitors anywhere in sight.Despite its leadership, there's plenty of trouble brewing thanks to ongoing legal wrangling with regulatory authorities on two continents and a slowdown in some of its core market segments. Not all is lost; there's still a powerful long-term trend that'll support its share price. But if you're thinking about buying this stock, it'll behoove you to understand the most important two red flags as well as the big green flag that's impacting Illumina today. Illumina is currently facing some serious legal trouble in the E.U. to the point where it constitutes a red flag for its near-term performance.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"


Viele Anleger setzen deshalb auf den Aktiv verwalteten Global Inflation Protection Basket. Informieren Sie sich über die breit gestreute Auswahl an robusten Aktien & ETFs.